this was shown to protect against Ang II-induced injury in the heart and aorta, potentially associated with inhibition of NOX4 expression and preservation of mitochondrial integrity, reduced the protein levels of NADPH oxidase 4 (NOX4) and TGF1 and expression of monocyte chemoattractant protein 1, and attenuated the proliferation of myofibroblasts culminating in reduced aortic wall thickness [81]
While this mechanism is central to how these medications help with appetite control, it also explains why digestive discomfort is one of the most frequently reported side effects during the first weeks of treatment
So again, it's sort of like a short-term investment in your health and you're building that muscle and then you have a chance of maintaining it
But between insurance coverage, copays, deductibles, and out-of-pocket costs, many patients struggle to understand what they'll actually pay and what they can afford
Looking ahead, the horizon for GLP-1 and related drugs is bright
Another official, Russell Wesdyk, encouraged the industry to pursue FDA investigational new drug applications and to conduct trials in humans to evaluate the substances